Warning: The NCBI web site requires JavaScript to function. more...
Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.
Bøyesen P, Hoff M, Odegård S, Haugeberg G, Syversen SW, Gaarder PI, Okkenhaug C, Kvien TK.
Arthritis Res Ther. 2009;11(4):R103. Epub 2009 Jul 1.
Related citations
Cortical hand bone loss after 1 year in early rheumatoid arthritis predicts radiographic hand joint damage at 5-year and 10-year follow-up.
Hoff M, Haugeberg G, Odegård S, Syversen S, Landewé R, van der Heijde D, Kvien TK.
Ann Rheum Dis. 2009 Mar;68(3):324-9. Epub 2008 Mar 13.
High anti-cyclic citrullinated peptide levels and an algorithm of four variables predict radiographic progression in patients with rheumatoid arthritis: results from a 10-year longitudinal study.
Syversen SW, Gaarder PI, Goll GL, Ødegård S, Haavardsholm EA, Mowinckel P, van der Heijde D, Landewé R, Kvien TK.
Ann Rheum Dis. 2008 Feb;67(2):212-7. Epub 2007 May 25.
The diagnostic utility of anti-cyclic citrullinated peptide antibodies, matrix metalloproteinase-3, rheumatoid factor, erythrocyte sedimentation rate, and C-reactive protein in patients with erosive and non-erosive rheumatoid arthritis.
Shovman O, Gilburd B, Zandman-Goddard G, Sherer Y, Orbach H, Gerli R, Shoenfeld Y.
Clin Dev Immunol. 2005 Sep;12(3):197-202.
Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
Ann Rheum Dis. 2006 Apr;65(4):453-8. Epub 2005 Sep 21.
Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).
Forslind K, Ahlmén M, Eberhardt K, Hafström I, Svensson B; BARFOT Study Group.
Ann Rheum Dis. 2004 Sep;63(9):1090-5.
Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
Ann Rheum Dis. 2009 Feb;68(2):201-8. Epub 2008 Apr 7.
Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis.
De Rycke L, Verhelst X, Kruithof E, Van den Bosch F, Hoffman IE, Veys EM, De Keyser F.
Ann Rheum Dis. 2005 Feb;64(2):299-302. Epub 2004 May 27.
The association of anti-CCP antibodies with disease activity in rheumatoid arthritis.
Serdaroğlu M, Cakirbay H, Değer O, Cengiz S, Kul S.
Rheumatol Int. 2008 Aug;28(10):965-70. Epub 2008 Apr 17.
Calprotectin (a major S100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis.
Hammer HB, Ødegård S, Syversen SW, Landewé R, van der Heijde D, Uhlig T, Mowinckel P, Kvien TK.
Ann Rheum Dis. 2010 Jan;69(1):150-4. Epub .
Prognostic laboratory markers of joint damage in rheumatoid arthritis.
Lindqvist E, Eberhardt K, Bendtzen K, Heinegård D, Saxne T.
Ann Rheum Dis. 2005 Feb;64(2):196-201. Epub 2004 Sep 30.
Hand bone loss as an outcome measure in established rheumatoid arthritis: 2-year observational study comparing cortical and total bone loss.
Hoff M, Haugeberg G, Kvien TK.
Arthritis Res Ther. 2007;9(4):R81.
Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.
Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.
Joint Bone Spine. 2009 May;76(3):248-53. Epub 2009 Feb 8.
Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study.
Syversen SW, Goll GL, van der Heijde D, Landewé R, Lie BA, Odegård S, Uhlig T, Gaarder PI, Kvien TK.
Ann Rheum Dis. 2010 Feb;69(2):345-51. Epub 2009 Jul 30.
Calprotectin (a major leucocyte protein) is associated with the levels of anti-CCP and rheumatoid factor in a longitudinal study of patients with very early rheumatoid arthritis.
Hammer HB, Haavardsholm EA, Kvien TK.
Scand J Rheumatol. 2008 May-Jun;37(3):179-82.
Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
del Val del Amo N, Ibanez Bosch R, Fito Manteca C, Gutierrez Polo R, Loza Cortina E.
Clin Exp Rheumatol. 2006 May-Jun;24(3):281-6.
The relationship between anti-cyclic citrullinated peptide and bone mineral density and radiographic damage in patients with rheumatoid arthritis.
Guler H, Turhanoglu AD, Ozer B, Ozer C, Balci A.
Scand J Rheumatol. 2008 Sep-Oct;37(5):337-42.
Synovial fluid levels of anti-cyclic citrullinated peptide antibodies and IgA rheumatoid factor in rheumatoid arthritis, psoriatic arthritis, and osteoarthritis.
Caspi D, Anouk M, Golan I, Paran D, Kaufman I, Wigler I, Levartovsky D, Litinsky I, Elkayam O.
Arthritis Rheum. 2006 Feb 15;55(1):53-6.
Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage.
Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A, Nicaise-Roland P, Sibilia J, Combe B.
Ann Rheum Dis. 2003 Feb;62(2):120-6.
Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.
Forslind K, Boonen A, Albertsson K, Hafström I, Svensson B; Barfot Study Group.
Scand J Rheumatol. 2009 Nov-Dec;38(6):431-8.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on